FOXP3 isoform expression (Full-length and Delta 2) & immunoregulatory markers (Tregs, IL-6, IL-10) in recurrent pregnancy loss: A South-Indian study
Journal of Reproductive Immunology · 2026-08 · 176 · 104920
DOI: 10.1016/j.jri.2026.104920 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2026-08. Verfasst von Sufaya Jameel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, School of Sciences, Maulana Azad National Urdu University, Gachibowli, Hyderabad, Telangana, India. Electronic address: Sufaya…. Hauptthemen laut MEDLINE: Forkhead Transcription Factors, Abortion, Habitual, T-Lymphocytes, Regulatory. Die Arbeit nennt 68 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Recurrent Pregnancy Loss (RPL), a complex reproductive disorder, with 50% of cases lacking a definitive cause. Immune dysregulation, particularly involving regulatory T cells (Tregs) and their master transcription factor FOXP3, is increasingly recognized as a critical contributor. FOXP3 exists in functionally distinct splice variants-full-length (FOXP3-FL) and exon 2-deleted (FOXP3-D2) whose roles in RPL remain poorly understood. To investigate FOXP3-FL and FOXP3-D2 expression, Treg populations, and serum IL-6 and IL-10 levels in second-trimester pregnant women with and without RPL. Sixty pregnant women were enrolled, equally divided into RPL and non-RPL (NRPL) groups. Treg populations and cytokine levels (IL-6 and IL-10) were assessed in all participants using flow cytometry and ELISA, respectively. FOXP3 isoform expression was further validated by Western blot analysis in a subset of 30 samples, including 15 NRPL and 15 RPL cases. Statistical comparisons included subgroup analysis (2 losses vs. >2 losses), with p < 0.05 considered significant. Compared to NRPL, RPL women had significantly higher age, BMI, and age at menarche, with reduced Treg percentage, FOXP3-FL, and IL-10 levels, and elevated FOXP3-D2 and IL-6. ROC analysis indicated strong diagnostic accuracy for Tregs, IL-6, and FOXP3-D2. Subgroup analysis revealed progressive FOXP3-D2 increase and FOXP3-FL decrease with the severity. The IL-6/IL-10 ratio was significantly higher in RPL, indicating a pro-inflammatory shift independent of loss severity. This is the first report of altered FOXP3 isoform expression in RPL, revealing a disrupted FOXP3-FL/D2 ratio that may underlie impaired Treg function and immune tolerance failure. FOXP3 isoforms, alongside cytokine markers, hold promise as novel immunological biomarkers for RPL diagnosis and risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Zoology, School of Sciences, Maulana Azad National Urdu University, Gachibowli, Hyderabad, Telangana, India. Electronic address: Sufaya19@gmail.com.
- Department of Zoology, School of Sciences, Maulana Azad National Urdu University, Gachibowli, Hyderabad, Telangana, India. Electronic address: rashmibhuwalka04@gmail.com.
- Department of Zoology, School of Sciences, Maulana Azad National Urdu University, Gachibowli, Hyderabad, Telangana, India. Electronic address: parveenjahan@manuu.edu.in.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Jameel, S., Bhuwalka, R., & Jahan, P. (2026). FOXP3 isoform expression (Full-length and Delta 2) & immunoregulatory markers (Tregs, IL-6, IL-10) in recurrent pregnancy loss: A South-Indian study. Journal of Reproductive Immunology, 176, 104920. https://doi.org/10.1016/j.jri.2026.104920
Vancouver
Jameel S, Bhuwalka R, Jahan P. FOXP3 isoform expression (Full-length and Delta 2) & immunoregulatory markers (Tregs, IL-6, IL-10) in recurrent pregnancy loss: A South-Indian study. Journal of Reproductive Immunology. 2026;176:104920. doi:10.1016/j.jri.2026.104920
BibTeX
@article{Jameel2026,
author = {Jameel, Sufaya and Bhuwalka, Rashmi and Jahan, Parveen},
title = {FOXP3 isoform expression (Full-length and Delta 2) & immunoregulatory markers (Tregs, IL-6, IL-10) in recurrent pregnancy loss: A South-Indian study},
journal = {Journal of Reproductive Immunology},
year = {2026},
volume = {176},
pages = {104920},
doi = {10.1016/j.jri.2026.104920}
}
EUVIMED